Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-12-19
1986-05-20
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
2602393B, A61K 3155, C07D26714
Patent
active
045901872
ABSTRACT:
The present invention provides certain novel 4,1-benzoxazepin-2(3H)-ones which are useful as inhibitors of phospholipase A.sub.2 and thus as inhibitors of arachidonate mobilization. These compounds are thus useful whenever it is medically necessary or desirable to inhibit the biosynthesis of the products of the arachidonic acid cascade.
REFERENCES:
patent: 3122554 (1984-02-01), Poos
patent: 3346565 (1967-10-01), Testa et al.
patent: 3598808 (1971-08-01), Szmuszkovicz
patent: 4297280 (1981-10-01), Hirai et al.
patent: 4307091 (1981-12-01), Brown et al.
patent: 4341704 (1982-07-01), Hirai et al.
Chemical Abstracts, vol. 63, cols. 18088-18089 (1965), abstracting Testa et al. in "Farmaco" (Pavia) (Ed. Sci.), vol. 20, No. 5, pp. 323-335 (1965).
Derwent Farmdoc 27355E and 25429C.
Ayer Donald E.
Szmuszkovicz Jacob
Wallach, deceased Donald P.
Bond Robert T.
The Upjohn Company
Welch Lawrence T.
LandOfFree
Phospholipase A.sub.2 inhibition using 4,1-benzoxazepine-2-(3H)- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase A.sub.2 inhibition using 4,1-benzoxazepine-2-(3H)-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase A.sub.2 inhibition using 4,1-benzoxazepine-2-(3H)- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2108963